These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma. Kurosawa M Clin Ther; 1995; 17(1):2-11; discussion 1. PubMed ID: 7758058 [TBL] [Abstract][Full Text] [Related]
4. [Effect of thromboxane A2 synthetase inhibitor (OKY-046) on leukotriene C4-induced airway hyperresponsiveness in guinea pigs]. Tsukagoshi H; Yodonawa S; Kurosawa M Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jun; 31(6):707-11. PubMed ID: 8345703 [TBL] [Abstract][Full Text] [Related]
5. Effect of OKY-046 (thromboxane A2 synthetase inhibitor) on exercise-induced asthma. Hoshino M; Fukushima Y J Asthma; 1991; 28(1):19-29. PubMed ID: 1849133 [TBL] [Abstract][Full Text] [Related]
6. [Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics]. Kanehiro A; Takahashi K; Soda R; Takata M; Takeda K; Sugano H; Yamagata K; Katagi Y; Kimura I Arerugi; 1992 May; 41(5):584-94. PubMed ID: 1325764 [TBL] [Abstract][Full Text] [Related]
7. [Effect of OKY-046 on airway hyperresponsiveness induced by ozone in dogs]. Nambu F; Imai T; Adachi M; Takahashi T Nihon Yakurigaku Zasshi; 1990 May; 95(5):271-7. PubMed ID: 2354834 [TBL] [Abstract][Full Text] [Related]
8. [Effects of a thromboxane-synthetase inhibitor in patients with chronic persistent coughing and no airwayhyperresponsiveness]. Nishi K; Mizuguchi M; Tachibana H; Watanabe K; Ooka T; Fujimura M; Matsuda T Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Sep; 35(9):927-33. PubMed ID: 9396248 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist). Misawa M; Chiba Y Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):341-9. PubMed ID: 7938906 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness. Takehana Y; Hamano S; Kikuchi S; Komatsu H; Okegawa T; Ikeda S Jpn J Pharmacol; 1990 Apr; 52(4):621-30. PubMed ID: 2160552 [TBL] [Abstract][Full Text] [Related]
11. The modulatory effect of antigen- and PAF-induced asthmatic reaction by aerosol administration of OKY-046 in guinea pigs. Tsai JJ; Tsai CF; Wang SR; Han SH Asian Pac J Allergy Immunol; 1995 Dec; 13(2):87-93. PubMed ID: 8703249 [TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 and related prostaglandins in airways. Devillier P; Bessard G Fundam Clin Pharmacol; 1997; 11(1):2-18. PubMed ID: 9182072 [TBL] [Abstract][Full Text] [Related]
13. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. Obase Y; Shimoda T; Matsuo N; Matsuse H; Asai S; Kohno S Chest; 1998 Oct; 114(4):1028-32. PubMed ID: 9792572 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs. Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650 [TBL] [Abstract][Full Text] [Related]
15. Effect of a thromboxane A2 synthetase inhibitor (OKY-046.HCl) on airway hyperresponsiveness in guinea pigs. Komatsu H; Takehana Y; Kikuchi S; Kojima M; Hamano S; Kusama H; Okegawa T; Ikeda S Eur J Pharmacol; 1990 Aug; 184(1):87-95. PubMed ID: 2170151 [TBL] [Abstract][Full Text] [Related]
16. Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice. Shi H; Yokoyama A; Kohno N; Hirasawa Y; Kondo K; Sakai K; Hiwada K Eur Respir J; 1998 Mar; 11(3):624-9. PubMed ID: 9596113 [TBL] [Abstract][Full Text] [Related]
17. The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor. Nagai H; Yakuo I; Nakatomi I; Inagaki N; Koda A Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):125-30. PubMed ID: 2710796 [TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 synthetase inhibitor (OKY-046) improves abnormal mucociliary transport in asthmatic patients. Kurashima K; Ogawa H; Ohka T; Fujimura M; Matsuda T Ann Allergy; 1992 Jan; 68(1):53-6. PubMed ID: 1736720 [TBL] [Abstract][Full Text] [Related]
19. [Chronic persistent coughing successfully treated with ozagrel]. Nishi K; Mizuguchi M; Tachibana H; Ooka T; Fujimura M; Matsuda T Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):350-4. PubMed ID: 8778479 [TBL] [Abstract][Full Text] [Related]
20. [Thromboxane A2 could be involved in bronchial hyperresponsiveness to methacholine in asthmatic subjects but not in bronchitic subjects]. Fujimura M; Sakamoto S; Kamio Y; Nishi K; Saito M; Miyake Y; Nomura M; Matsuda T Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):121-5. PubMed ID: 2192187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]